Then, our studied revealed that the SP phenotype and ABCG2 function rather than ABCG2 expression was correlated with drug resistance and disease progression in CML patients, which was mediated at least partially by p-Akt activation. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.